| Literature DB >> 24954725 |
Masaki Okawara1, Fumie Hashimoto1, Hiroaki Todo1, Kenji Sugibayashi1, Yoshihiro Tokudome2.
Abstract
Diosgenin, found in wild yam (Dioscorea villosa), has been shown to ameliorate diabetes and hyperlipidemia, increase cell proliferation in a human 3D skin model, and inhibits melanin production in B16 melanoma cells. It is also an active element in cosmeceutical and dietary supplements. Although the bioavailability of diosgenin is low due to its poor solubility and intestinal permeability, it was subsequently improved using a β-cyclodextrin (β-CD) inclusion complex. Recently liquid crystals (LCs) were shown to enhance the bioavailability of poorly water-soluble drugs. The purpose in the present study was to prepare diosgenin LCs and investigate the interaction between LC and β-CD in order to improve its bioavailability of diosgenin. Crystallinity and particle diameters of LCs in water were determined by small angle X-ray scattering (SAXS) and Zetasizer. Pharmacokinetic parameters were calculated using the plasma content of diosgenin after its oral administration to Wistar rats. Regarding the formation of glyceryl monooleate (GMO) and phytantriol (PHY) LC, SAXS patterns showed the hexagonal and cubic phases, respectively. Bioavailability was significantly enhanced after oral administration of LCs prepared by GMO than after diosgenin alone. The bioavailability was further improved with the combination of LC and β-CD than LC and water.Entities:
Keywords: Diosgenin; Glyceryl monooleate; Liquid crystal; Oral administration; Phytantriol; β-cyclodextrin
Mesh:
Substances:
Year: 2014 PMID: 24954725 DOI: 10.1016/j.ijpharm.2014.06.032
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875